Summary.-Immunofluorescent assessment of hormone receptors in melanocytic tumours is quite feasible without loss of diagnostic material, in contrast to the impracticability of quantitative biochemical assays. Using this method, oestrogen receptors were demonstrated in 4/6, and progesterone receptors in 3/5 patients with metastatic melanoma. Receptors were not found in 3 patients with primary cutaneous melanomas of the superficial spreading type. Progesterone receptors were present in the junctional component of a naevus from one healthy person.
ALTHOUGH THERE IS apparently no sex difference in the incidence of malignant melanoma, Shaw et al. (1978) found that prognosis and survival favoured women of child-bearing age. They also concluded that the disease may have a capacity to metastasize more slowly in women and that the sites of primary lesions are different in men and women. The data of Shiu et al. (1976) strongly suggested an adverse influence of pregnancy on women with Stage II melanoma. These observations, in conjunction with the rarity of prepubertal melanomas, suggest that the developmental and clinical behaviour of malignant melanoma may be influenced by the hormonal status of the individual. This inference is supported by evidence of activation of melanoma by the administration of oestrogens (Sadoff et al., 1973) and by a specific oestrogenic effect in some melanoma patients who responded to 6a-methyl-pregnenetrione which has antioestrogen and weak glucocorticoid properties (Johnson et al., 1966) . Conversely, therapeutic responses have been noted with oestrogen (Fisher et al., 1978) and with oestrogen linked to nitrogen mustard (Didolkar et al., 1978) .
A mechanism by which oestrogen could affect melanoma cells has been suggested by the demonstration of oestrogen and progesterone receptors estimated biochemically in cytosol homogenates, by a number of groups (Fisher et al., 1976 (Fisher et al., , 1978 Kokoschka et al., 1979; Chaudhuri et al., 1980; Rumke et al., 1980) . Since knowledge of the hormone-receptor status of melanoma tumours could have important therapeutic implications, were it possible to extrapolate from the successful outcome of endocrine therapy in a proportion of receptor-bearing breast cancers (McGuire et al., 1978) , we felt that these biochemical results justified further investigation.
Quantitative biochemical methods are not always applicable to malignant melanoma, especially in primary tumours, since they are usually too small for part of the tumour to be spared for separate assay. Methods of demonstrating oestrogen (RE) and progesterone receptors (RP) in breastcancer cells by indirect immunofluorescent techniques have been developed by several laboratories (Mercer, 1978; Pertschuk et al., 1978; Nenci et al., 1978) . For breast carcinoma, Pertschuk et al. were able to show a statistically significant agreement for their positive findings, between RE demonstrated by indirect immunofluorescence and RE detected by the conventional dextran-charcoal biochemical assay. In the present study, we have overcome the problems inherent in the assessment of hormone receptors in small tumours, by applying immunofluorescent methods similar to those developed for carcinoma of the breast, on the melanocytic tumours in our series. We have confirmed the findings from the cytosol assays. This paper reports our preliminary results.
PATIENTS
The details of the melanoma patients are given in the Table. The naevi were removed from persons without melanoma.
MATERIALS AND METHODS
Handling of specimens-.Tumour specimens were examined and dissected within seconds of excision in the theatre suite, and representative blocks for immunofluorescent receptor assay immediately snap-frozen in liquid N2. The rest of the specimen was processed for histological diagnosis. When the tumour was of sufficient size, tissue was also taken for biochemical assay of hormone receptors.
Immunofluorescent techniques -Specimens were stored at -70°C and examined within 3 days of their excision. Four-micron sections were cut in a cryostat at -20°C on to gelatincoated slides, dried in air for 10-15 sec and stored in the cryostat until sectioning was completed. They were then processed immediately by the method of Mercer (1978) The anti-hormone sera were produced in sheep by immunization with oestradiol 17/3-6 CMO-BSA or progesterone Ila-hemisuccinate-BSA in Freund's complete adjuvant. They were tested for specificity against a variety of chemically related steroids in the following way: a standard curve was established from the results obtained by incubating varying amounts of unlabelled specific hormone, in the range 12-5-500 pg, with a fixed amount (of the order of 10 nCi) of specific (3H-) hormone, in the presence of a standard volume of antiserum appropriately diluted on the basis of its predetermined titre (Cox et al., 1979) . At the same time, varying amounts of unlabelled potentially crossreacting steroids from 25 pg to 100 ng were reacted as for the standard curve procedure and compared with results for the measurements with the homologous hormone. The percentage cross-reactivity was calculated as described (Abraham, 1969) . The cross-reaction of the anti-oestradiol serum was below 1% with oestrone or oestriol, and below 0.10% with testosterone, androstenedione, progesterone, 1 7a-hydroxy progesterone and cortisol. The cross-reaction of the antiprogesterone serum was below 1% with 17a-hydroxy-progesterone and pregnenolone, and below 0-1 % with cortisol.
The following controls were included for each specimen: incubation of sections with normal sheep serum in place of sheep antihormone sera to detect nonspecific binding of serum; incubation with PBS in place of antihormone serum to detect nonspecific binding of the fluorescein conjugate; incubation with PBS in place of hormone solution to detect the presence of endogenous hormone fixed to receptors. Other controls were the use of antihormone sera absorbed with specific hormone, competitive-binding tests of the RE reaction by coincubation with oestradiol and 10-4M diethyl silboestrol or nitromifene citrate, the absence of a significant reaction with FITCconjugated goat anti-rabbit globulins and the absence of a reaction with receptor-negative tissue (human muscle). Results 1+;25%-50%:2+;50%-75%:3+; >75%:
Biochemical assay of tumour cytosols. Three of the specimens were large metastases of malignant melanoma, so that sufficient tissue was available for biochemical assay of RE and RP, as well as morphological assessment. In one smaller sample, only tissue for RE assay could be spared for testing. The methods described by Hawkins et al. (1975) and Pichon & Milgrom (1977) were used, with R5020 as a progesterone substitute.
RESULTS

Pathology of tumours
Tumours from 13 patients were examined. Six of these were metastatic malignant melanomas, 3 primary cutaneous malignant melanomas, 3 benign compound naevi and 1 benign intradermal naevus.
Biochemical assays
Analysis of the tumour cytosols in the 4 patients tested for RE showed 3 positive. Of the 3 patients tested for RP 2 were positive. The receptor values are given in the Table. In Patients 1 and 4, 2 metastatic nodules were available for study: there was a variation in the detectable quantity of receptors between the 2 nodules, for both patients.
Immunofluorescent demonstration of hormone receptors Malignant melanomas.-Four (1 female, 3 male) of 9 patients had RE and 3 (1 female, 2 male) of 7 had RP (see Table) .
The receptors were located mainly in the cytoplasm (Fig. 1) . In the positive tumours, very slight traces of "endogenous" oestrogen and progesterone were sometimes seen, but this may have been attributable to small quantities of hormone in the human serum pool used in the incubation buffer (oestrogen, 55 pg/ml; progesterone, < 500 pg/ml).
All the positive reactions occurred in patients with metastatic nodules. Their graded reactions for percentages of receptor-positive cells are shown in the Table. The receptor-bearing cells usually occurred fairly randomly throughout the examined area of the tumour section. But in Patient 4 they were present in distinct clusters ( In the 4 patients (1, 4, 5, and 6) in whom both immunofluorescent and biochemical tests were applied, the tumours showed consistent results for the presence of receptors by both assays, except for nodule (2) from Patient 1 and nodule (1) from Patient 4.
In the tumour from Patient 5, in addition to a reaction for cytoplasmic oestradiol binding, immune-reactive hormone was frequently found in perinuclear rings in the same cells (Fig. 2) .
Benign naevi.-A compound naevus from Patient 10 showed cytoplasmic RP in a group of larger "junctional" cells in the papillary dermis and junctional zone, but the smaller intradermal melanocytic cells were quite negative (Fig. 3) (Pertschuk et al., 1978; Lee, 1980 (Watson & Muldoon, 1977) and lysosomal (Szego, 1974) receptors which cannot be detected in the cytosol assay are included in the cytoplasmic steroid-binding sites Besides binding to RP, progesterone also binds to androgen and glucocorticoid receptors (Horwitz et al., 1975; Ojasoo & Raynaud, 1978) ; the positive immunofluorescent reactions for RP seen in our tests possibly represent a summation of the reactions with all 3 receptors. This could be an explanation for the high proportion of immunofluorescent RP+ cells in the 2 nodules from Patient 4, compared with the negative or low (15 fmol/mg protein) values detected by biochemical assay (Table) . We are proceeding to elucidate the specificity of the progesterone reactions by competitive-binding studies, and by testing tumours with antisera specific for androgen and glucocorticoid hormones.
The presence of hormone receptors in melanoma has not so far been shown to correlate with clinical responses to endocrine manipulation (Fisher et al., 1978; Creagan et al., 1980; Papac et al., 1980; Rumke et al., 1980) . Results from a trial by Karakousis et al. (1980) (Fisher et al., 1976; Karakousis et al., 1980; Rumke et al., 1980) It has been suggested that defects in the interaction of receptor and hormone, and their translocation, may account for variations in the outcome of hormone therapy of breast cancer (McGuire et al., 1978) . There may be impairment of the translocation of the receptor-hormone complex to the nucleus. We suggest that the perinuclear rings of immune-reactive oestradiol in Patient 5 may indicate a defect in the access to the nucleus of receptor-oestradiol complexes across the nuclear membrane (Nenci et al., 1978) . Since the presence of RP is considered to be a phenotypic expression of effective osetrogen action, their absence from Patient 5 may have been due to a failure of cytosol-to-nucleus transport. Knowledge of such a defect may assist in predicting tumour behaviour and response to therapy.
We have found that 5/6 metastatic melanomas carried hormone receptors. On the other hand, the 3 primary cutaneous melanomas were negative for both RE and RP, though RP was not tested for in one case. All the primary melanomas were of the superficial spreading type. Two showed early invasion (Level II) to a depth of 0-46 mm and 0 94 mm respectively, and the third showed invasion of the reticular dermis (Level IV) to a thickness of 2-73 mm. It would be interesting to ascertain whether receptors are always absent in superficial spreading melanomas, and whether they are present in other types of melanoma. As they were present in all but one of the metastatic melanomas, one could speculate that the presence of receptors may be an indication of metastatic potential. Clearly, many more cases need to be studied.
The differential diagnosis of some benign melanocytic naevi from malignant melanoma is often problematical. Indeed it is assumed that at least some melanomas arise from naevi. For these reasons we have tested for hormone receptors in 4 benign naevi. All were negative, except that the junctional component of one compound naevus contained RP. Oestrogen-binding in a significant proportion of benign naevi from patients with melanoma has been reported elsewhere (Chaudhuri et al., 1980) ; none was found by that group in naevi from patients without melanoma. Our 4 patients did not have detectable melanoma. In view of the observations of Chaudhuri et al., our positive finding suggests that the existence of hormone receptors in naevi could be an indicator of predisposition to malignancy. Again further cases relating to this aspect of our work need to be documented.
